...
首页> 外文期刊>Scientific reports. >Molecular diagnosis of pediatric patients with citrin deficiency in China: SLC25A13 mutation spectrum and the geographic distribution
【24h】

Molecular diagnosis of pediatric patients with citrin deficiency in China: SLC25A13 mutation spectrum and the geographic distribution

机译:中国甘油素缺乏患者的分子诊断:SLC25A13突变谱与地理分布

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Citrin deficiency (CD) is a Mendelian disease due to biallelic mutations of SLC25A13 gene. Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) is the major pediatric CD phenotype, and its definite diagnosis relies on SLC25A13 genetic analysis. China is a vast country with a huge population, but the SLC25A13 genotypic features of CD patients in our country remains far from being well clarified. Via sophisticated molecular analysis, this study diagnosed 154 new CD patients in mainland China and identified 9 novel deleterious SLC25A13 mutations, i.e. c.103A??G, [c.329?-?154_c.468?+?2352del2646; c.468?+?2392_c.468?+?2393ins23], c.493C??T, c.755?-?1G??C, c.845_c.848?+?1delG, c.933_c.933?+?1insGCAG, c.1381G??T, c.1452?+?1G??A and c.1706_1707delTA. Among the 274 CD patients diagnosed by our group thus far, 41 SLC25A13 mutations/variations were detected. The 7 mutations c.775C??T, c.851_854del4, c.1078C??T, IVS11?+?1G??A, c.1364G??T, c.1399C??T and IVS16ins3kb demonstrated significantly different geographic distribution. Among the total 53 identified genotypes, only c.851_854del4/c.851_854del4 and c.851_854del4/c.1399C??T presented different geographic distribution. The northern population had a higher level of SLC25A13 allelic heterogeneity than those in the south. These findings enriched the SLC25A13 mutation spectrum and brought new insights into the geographic distribution of the variations and genotypes, providing reliable evidences for NICCD definite diagnosis and for the determination of relevant molecular targets in different Chinese areas.
机译:CITRIN缺乏(CD)是由于SLC25A13基因的双峰突变引起的孟德利疾病。由甘油蛋白缺乏(NiCCD)引起的新生儿肝内胆汁淤积是主要的儿科CD表型,其确定诊断依赖于SLC25A13遗传分析。中国是一个庞大的国家,人口庞大,但我国CD患者的SLC25A13基因型特征仍然远未澄清。通过复杂的分子分析,本研究诊断出154名新型CD患者在中国大陆,并确定了9名新型有害SLC25A13突变,即C.103A?>?G,[C.329吗? - + 154_C.468?+?2352Del2646; C.468?+?2392_C.468?+?2393辛23],C.493C?>?T,C.755? - α - 1G?>?C,C.845_C.848?+?1delg,C.933_C.933 ?+?1个,C.1381G?>?T,C.1452?+?1G?>?A和C.1706_1707Delta。在迄今为止诊断的274名CD患者中,检测到41个SLC25A13突变/变化。 7突变C.775C?>?T,C.851_854DEL4,C.1078C?>?T,IVS11?+?1G?>?A,C.1364G?>?T,C.1399C ???T和IVS16INS3KB展示了显着不同的地理分布。在总53个鉴定的基因型中,仅C.851_854DEL4 / C.851_854DEL4和C.851_854DEL4 / C.1399C ???T呈现出不同的地理分布。北方人口较高的SLC25A13等位基因异质性高于南方的水平。这些发现丰富了SLC25A13突变谱,并对变化和基因型的地理分布带来了新的见解,为NiCCD确定诊断提供了可靠的证据,并确定了不同中国地区的相关分子靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号